Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

4

Portfolio Exits

3

About David Li

David Li is Co-Founder and CEO of Third Ave Labs, an independent startup advisor and consultant, and angel investor.

David Li Headquarter Location

California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest David Li News

NeurologyLive Announces Giants of Multiple Sclerosis Inaugural Class of Inductees

Jun 6, 2022

NeurologyLive Giants of Multiple Sclerosis inductees, from left to right: Lacey E. Bromley, PT, DPT, PhD, NCS (accepting on behalf of the late Susan E. Bennett, PT, DPT, EdD, NCS, MSCS); Kathleen Brandfass, MS, PT; Peter A. Calabresi, MD; Nancy Ross, PharmD, BCACP, MSCS, CSP; Valerie Stickel-Diehl, RN, MS, MSCN; Frederick W. Foley, PhD; June Halper, MSN, APN-C, MSCN, FAAN; Victor M. Rivera, MD, FAAN; and David Li, MD, FRCPC. Not present: Ellen S. Lathi, MD and T. Jock Murray, OC, ONS, MD, FAAN, MACP, FACPC, FRCP, FCAHS NeurologyLive and the Consortium of Multiple Sclerosis Centers ( CMSC ) announce the inaugural class of Giants of Multiple Sclerosis inductees. Giants of Multiple Sclerosis is a premier neuroscience award that celebrates pioneers, innovators and future generations of leaders selected by their peers for their remarkable achievements in multiple sclerosis. The award ceremony, supported by  Atara Bio  and  Bristol Myers Squibb , took place on Thursday, June 2, 2022, during the CMSC Annual Meeting at the Gaylord National Resort & Convention Center in National Harbor, Md. Launched in 2021, the Giants of Multiple Sclerosis program recognizes individuals who have reached landmark successes within the field of multiple sclerosis. Out of many nominations, the steering committed selected only nine multiple sclerosis health care professionals to join the prestigious 2022 inaugural class. The Giants of Multiple Sclerosis steering committee is a group of health care professionals – all giants in their own right – who came together to provide guidance to NeurologyLive on the development of this new recognition initiative. The steering committee selects the finalists and, ultimately, the inductees in each category from the nominations submitted late last year. “We’d like to congratulate each and every single member of this year’s class of inductees on this enormous honor,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of NeurologyLive. “It is no surprise that these health care professionals were recognized for their contributions to multiple sclerosis and dedication to this vital practice. They are all pioneers and leaders within the multiple sclerosis community.” The 2022 honorees by award category are as follows: Global Impact: Victor M. Rivera, MD, FAAN – Baylor College of Medicine Mental Health: Frederick W. Foley, PhD – Yeshiva University/Holy Name Medical Center Neuroimaging: David Li, MD, FRCPC – University of British Columbia Neurology: T. Jock Murray, OC, ONS, MD, FAAN, MACP, FACPC, FRCP, FCAHS – Dalhousie University MS Research Unit Nursing: Valerie Stickel-Diehl, RN, MS, MSCN – Ruan Neurology at MercyOne Hospital Patient Care: Ellen S. Lathi, MD – The Elliot Lewis Center for Multiple Sclerosis Care Pharmacy: Nancy Ross, PharmD, BCACP, MSCS, CSP – The Multiple Sclerosis Center of Atlanta Research: Peter A. Calabresi, MD – Johns Hopkins University School of Medicine Rehabilitation: Kathleen Brandfass, MS, PT – UPMC/Centers for Rehab Services The Giants of Multiple Sclerosis steering committee, NeurologyLive and CMSC also honored two individuals for their contributions: The Giants of Multiple Sclerosis Legacy Award: The late Susan E. Bennett, PT, DPT, EdD, NCS, MSCS – Bennett Rehabilitation Institute/University at Buffalo/D’Youville University; accepted by Lacey E. Bromley, PT, DPT, PhD, NCS, on behalf of Dr. Bennett The Giants of Multiple Sclerosis Visionary Award: June Halper, MSN, APN-C, MSCN, FAAN – The Consortium of Multiple Sclerosis Centers [Source(s): NeurologyLive, GlobeNewswire]

David Li Investments

4 Investments

David Li has made 4 investments. Their latest investment was in Bigo as part of their Series D on June 6, 2018.

CBI Logo

David Li Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/5/2018

Series D

Bigo

$272M

Yes

3

3/14/2012

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2011

Seed

Subscribe to see more

$99M

Subscribe to see more

10

1/15/2010

Seed VC

Subscribe to see more

Subscribe to see more

0

Date

6/5/2018

3/14/2012

1/7/2011

1/15/2010

Round

Series D

Series A

Seed

Seed VC

Company

Bigo

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$272M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

10

10

0

David Li Portfolio Exits

3 Portfolio Exits

David Li has 3 portfolio exits. Their latest portfolio exit was Bigo on March 04, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/4/2019

Acquired

$99M

13

11/18/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/14/2013

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/4/2019

11/18/2014

1/14/2013

Exit

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

13

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.